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Introduction
Molecular disruptions of synaptic function have recently emerged as important causes of neurological disorders 1 . For example, antibodies to N-methyl-D-aspartate receptors (NMDAR-Ab) have been identified as an important, treatable cause of autoimmune encephalitis 2 , with a particularly high incidence in children who make up approximately 40% of patients. Patients with NMDAR-Ab encephalitis show a diverse range of associated symptoms; including behavioural changes, movement disorders and seizures 3, 4 . Important aspects of the clinical presentation are electroencephalography (EEG) abnormalities, which have been reported in up to 90% of patients undergoing EEG monitoring; between 20-60% of patients also have overt epileptiform discharges or electrographic seizures 5, 6 . While there are EEG features that are thought to be relatively specific for NMDAR-Ab encephalitis (e.g. extreme delta brush) 6 , the more common EEG abnormalities are diverse and non-specific, with global abnormalities broadly associated with more severe disease 7, 8 .
At the whole organism level, NMDAR-Ab cause an increased seizure susceptibility: Passive transfer of patient immunoglobulin (IgG) containing NMDAR-Ab into a mouse model causes increased susceptibility to chemically induced seizures 9 . NMDAR-Ab directly affect glutamate transmission through reversible loss of NMDARs, resulting in a reduction of miniature excitatory post synaptic currents (mEPSCs) in brain slices 10, 11 . NMDAR hypofunction is also a hallmark of psychiatric conditions, such as schizophrenia and acute psychosis 12, 13 -whose clinical features resemble the neuropsychiatric and behavioural symptoms also seen in NMDAR-Ab encephalitis.
Linking NMDA receptor hypofunction at the cellular level, and a predisposition to seizures at the systemic scale is challenging. In the simplified view of epileptic seizures as a consequence of excitationinhibition imbalance 14 , one would expect NMDAR hypofunction to be associated with a reduction of excitation, thus a decrease in seizure susceptibility. Yet at the level of neuronal ensembles, synaptic molecular changes may have a multitude of different emergent effects depending on their effects on both excitatory and inhibitory components of the neuronal circuit. In relation to NMDAR, observations in a range of experimental models motivate several mechanistic hypotheses explaining the effects of NMDAR hypofunction: These include (i) altered excitatory dynamics with a reduction in late excitatory post-synaptic potential components 11 ; (ii) secondary neurotoxicity, reducing the number of functional excitatory connections 15 ; (iii) a reduction of cortical inhibitory interneuron activity 16 . Furthermore, paradoxical changes in excitatory and inhibitory transmission -resulting from maladaptive homeostatic changes -have been proposed as underlying NMDAR-Ab associated abnormalities at different temporal scales 10 .
Relating observations of pathological brain dynamics to these specific hypotheses is challenging. In a highly non-linear dynamic system, such as the brain, the link between synaptic abnormalities and whole brain responses is seldom intuitive or predictable. Neuronal systems are hierarchically structured and each observational scale constrained by larger scale processes, as well as interacting with emergent properties arising from smaller scales 17 . Some of these multi-scale dynamics can be successfully captured in computational models of neural population dynamics, which have been integrated into validated analytic frameworks, such as dynamic causal modelling (DCM) [18] [19] [20] .
DCM rests on 'mesoscale' neural mass models that capture the average behaviours of neural populations at roughly the scale of a cortical column -the model used here is representative of generic features of layered cortical architectures and is often referred to as the canonical microcircuit or CMC 21 . The parameters of these models (which describe features such as synaptic connection strengths, and population response dynamics) can be fitted to macroscale neurophysiological recordings such as EEG, or LFP recordings and competing models can be ranked according to their model evidence.
Here, we report the results of a dynamic causal modelling analysis of (a) changes in spontaneous (resting state) activity in a subacute mouse model of NMDAR-Ab encephalitis, and (b) abnormal EEG paroxysms observed in a series of paediatric patients with established NMDAR-Ab encephalitis. In a two-stage analysis, we first model the NMDAR-Ab effect in the mouse model; using DCM to identify a minimal set of synaptic parameters required to produce the NMDAR-Ab effect on observed LFP recordings. Using estimates of fluctuations in the parameters identified -based on patient EEG datawe then asked whether the presence of NMDAR-Ab alters network responses to estimated parameter fluctuations. This modelling integrates evidence from patients and experimental animals and provides direct evidence linking microscale observations on NMDAR-Ab-associated dysfunction with dynamic brain phenotypes. This approach enabled us to ask whether NMDAR-Ab-associated cortical dysfunction can be explained by changes in inhibitory or excitatory cortical coupling, or the synaptic dynamics of cortical transmission. Furthermore, we were able to test in silico whether (a) paroxysmal abnormalities seen in human patients can be explained by intrinsic, normal fluctuations in cortical coupling -on the background of pathological cortical microcircuitry -or (b) whether they are representative of pathological fluctuations per se. This distinction may have implications in terms of the appropriate treatment of paroxysmal EEG abnormalities -either through resetting the system, or controlling abnormal fluctuations.
Results

NMDAR-Ab alter the dynamic response to acute chemoconvulsants in mice
Cortical dysfunction associated with NMDAR-Ab was tested in C57BL/6 mice using a two-by-two design. This design tested for the effects of NMDAR-Ab (delivered via intracerebroventricular injection), the acute chemoconvulsant pentylenetetrazole (PTZ, delivered via a later intraperitoneal injection), and their interaction. LFPs were recorded wirelessly in freely behaving animals and 45 minutes of recordings pre-and post PTZ injection of 8 NMDAR-Ab positive and 5 control animals were included for the analysis reported here. In NMDAR-Ab positive IgG treated animals, PTZ causes a profound increase in low frequency power, which is also visible as high power slow waves in segments; largely without overt epileptiform activity (example shown). Average Fourier spectra across animals are shown for 45 minute recordings pre-and post-PTZ injections, shading indicates the 95% confidence interval. Example 5s LFP segments are also shown for individual animals pre-and post-PTZ injections.
Antibodies alone caused a moderate suppression of the LFP signal across low frequency bands (delta and theta range) in the NMDAR-Ab positive mice. However, additional exposure to PTZ revealed a marked difference between NMDAR-Ab positive and control mice, with a large increase of low frequency (delta-band, 1-4Hz) power in the antibody positive treated mice only (Fig 1) . Analysis of variance (ANOVA) revealed a significant main effect of NMDAR-Ab on log-delta-band power [F(1,4601) = 9.67; p = 0.002]; and a significant interaction between NMDAR-Ab and PTZ exposure [F(1,4061) = 85.05; p < 0.001]. A PTZ-induced increase in paroxysmal fast activity consistent with epileptic seizures was observed in the NMDAR-Ab positive IgG treated mice compared to control animals, which has previously been reported elsewhere 9 . An example of the induced, non-epileptiform slow activity is seen in the bottom panel of Fig 1B. These slow wave cortical dynamic abnormalities were further analysed in the modelling below. sp: superficial pyramidal cells, ss: spiny stellate cells, ii: inhibitory interneurons, dp: deep pyramidal cells
NMDAR-Ab potentiate PTZ-induced effects in cortical microcircuitry in mice
To explain the observed differences in spontaneous activity, a hierarchical dynamic causal model was used to infer parameter changes associated with the experimental variables over time (i.e. NMDAR-Ab exposure, PTZ infusion, Antibody-PTZ interaction). In brief, a sliding window (length = 30s, step size = 15s) was used to estimate the mean power-spectra over successive time points. Each time window was then modelled as the steady state output of a canonical microcircuit (CMC) model 21 with fixed synaptic parameters. By repeating this analysis over windows, we could then identify fluctuations in synaptic parameters that corresponded to the experimental interventions. Across windows, the evolution of spectral patterns was captured well for all experimental conditions (Fig 2A-B) . To infer experimental effects associated changes in the DCM parameters, the sequence of parameter estimates was then modelled using a parametric empirical Bayesian (PEB) approach 22 . Here, slow fluctuations of cortical coupling were modelled as between-window changes in the synaptic parameters estimated within-window (see Papadopoulou et al. 23 for a worked example). We included three main experimental effects of interest: (a) NMDAR-Ab, (b) PTZ, and (c) an NMDAR-Ab x PTZ interaction term (Fig 2C) . The neuronal parameters that affect the spectral composition of spontaneous neuronal activity correspond roughly to the mechanistic hypotheses outlined above: (i) time constants of the neuronal populations τ describe the dynamics of neuronal population responses; (ii) excitatory coupling parameters g e describe the strength of excitatory between-population connections; (iii) inhibitory coupling parameters g i represent the strength of inhibitory between-population connections, whilst modulatory coupling parameters g m represent the strength of inhibitory self-connections 21 .
Spectral changes associated with NMDAR-Ab, PTZ exposure and the interaction were each associated with several parameter changes. The biggest effects were associated with PTZ exposure, with a decrease in the superficial pyramidal cell population time constant (i.e. a faster return to baseline after perturbation), an increase in the spiny stellate population time constant (i.e. a slower return to baseline after perturbation), and an increase in the excitatory connectivity from spiny stellate to superficial pyramidal cells. Notably those changes were further potentiated by NMDAR-Ab and the NMDAR-Ab x PTZ interaction (Fig 2D) . 
Shifts in synaptic dynamics underlie emergence of low frequency power in mice
We further investigated the effect of changes in synaptic parameters on the main spectral data feature of interest (i.e. delta-band power). For this, we first performed a principal component analysis over the slow (between time-window) fluctuations of time constants (Fig 3A) and connection strengths (Fig 3B) , retaining the first principal component of each. This analysis showed that most of the variance over time can be explained by fluctuations in a small subset of parameters; specifically, the time constants of superficial pyramidal and spiny stellate cells, and the excitatory coupling between them (as is apparent in the analysis in Fig 2) . We use these two components to project synaptic parameter estimates at each point in time (i.e. window) onto the two dimensions explaining most of the variance (i.e. one time constant component and one connection strength component). To characterise different locations in this parameter spacein terms of the neuronal dynamics generated by the parameters -we used the mean delta band power. This functional characterisation of parameter space is shown (in log-scale) with a colour code and as isoclines indicating mean delta-band power centiles: see Fig 3C. Whilst there is variation in delta-band power associated with both the time constant (x-axis) and the connection strength (y-axis) parameters, the time constants have the greatest effect on delta power: The difference between controls and NMDAR-Ab positive animals in the delta-band power post-PTZ is largely conferred by shifting the time constant component, causing it to cross the 75 th delta-band power centile much more frequently than in controls (Fig 3D) . This differential effect of PTZ can be seen clearly by comparing the orange and purple dots in Fig 3C. 
EEG paroxysms in patients are caused by fluctuations in synaptic dynamics
To identify which synaptic parameters cause paroxysmal EEG abnormalities commonly observed in NMDAR-Ab encephalitis, we used the above CMC model to perform a DCM analysis of 8 paediatric cases; for which EEG recordings were available and contained visually apparent EEG paroxysms. Briefly, routine visual EEG analysis was performed to identify paroxysmal abnormalities by two EEGtrained clinicians (RER, GC, see Tab 1). For each patient, 2s time windows containing spontaneous activity, short isolated paroxysms, or rhythmic / ongoing epileptiform activity were extracted and used for further analysis (Fig 4A) Cortical source estimation for the paroxysmal EEG activity was performed and 'virtual electrode' responses extracted from the most active sources 24 . For each patient, DCMs were independently fitted to power spectral density averages of each available condition (e.g. background, short paroxysms, ongoing rhythmic activity, Fig 4B) . Individually fitted DCMs (with near perfect model fits) (Fig 4C) were subsequently combined in (within-patient) between-condition hierarchical (PEB) models that explained the condition specific differences with changes in synaptic time constants (τ), between-population inhibitory connections (g i ), between-population excitatory connections (g e ), or within population modulatory connections (g m ). Across participants, models explaining spectral differences as arising from differences in time constants offer the best explanation of the virtual electrode data (with an exceedance probability of >95%, Fig 4D) .
NMDAR-Ab alter the response to intrinsic fluctuations in synaptic dynamics
The DCM of human data provides us with an estimate of condition-specific changes in synaptic parameters. We extracted the first principal component of these changes across all conditions and subjects, and applied them to the control and the NMDAR-Ab positive mouse CMC model.
The differences between the parameter estimates from the control and NMDAR-Ab positive model result in different spectral outputs; even when applying the same time constant changes. Overall, the NMDAR-Ab positive context results in higher delta-band power and less high frequency power (Fig 5A-B) . Crucially, delta power was higher in the NMDAR-Ab positive model across a wide range of time constant fluctuations (Fig 5C) . Furthermore, small changes in the synaptic parameters identified with the patient data are caused large changes in delta power in, and only in, the NMDAR-Ab positive model. This is manifest as low frequency paroxysmal activity, when the synaptic parameters change slightly in the NMDAR-Ab positive model, but not the control (Fig 5D) . Technically, this abrupt change in dynamics with a small change in parameters is known as a phase transition; suggesting that antibody-positive effects on synaptic coupling move the network towards a critical regime in which small fluctuations in synaptic time constants produce qualitatively different dynamics (i.e., paroxysmal EEG abnormalities).
Discussion
The study presented here reveals common synaptic mechanisms underlying a range of electrophysiological disturbances associated with NMDAR-Ab in a mouse model and paediatric patients: NMDAR-Ab cause a shift in cortical synaptic parameters that is associated with increased low frequency oscillations and predisposes to the low slow wave paroxysms seen in the clinical EEG recordings.
NMDAR-Ab are associated with high-amplitude low-frequency discharges
NMDAR-Ab cause changes in the spectral composition of resting state LFP of the mouse strain tested. These differences are further revealed on additional exposure to PTZ, with a large PTZ-induced increase in mean delta power in the presence of NMDAR-Ab. The increased delta on the LFP in this mouse model is largely due to intermittent rhythmic slowing; without overt epileptic spikes. Previous analysis of seizure events show that NMDAR-Ab also lower the seizure threshold in these mice 9 , but seizure events fall largely outside the frequency spectrum analysed here. These spectral changes are in keeping with the kind of abnormalities seen in NMDAR-Ab encephalitis, clinically -with background slowing with or without additional slow wave paroxysms.
An increase in the power of slow frequency components in an EEG or LFP recording is thought to be associated with increased synchronisation of local cortical firing, which itself is regulated by a range of interacting cortical and subcortical systems (e.g. thalamocortical loops 25, 26 , brain stem monoamine arousal systems 27 and intrinsic cortical effects such as astrocytic regulation of synaptic function 28 ).
Firing synchrony can occur physiologically (e.g. during sleep), can be associated with non-specific cortical dysfunction (e.g. in the context of an encephalopathy), or be a component of epileptic discharges (apparent in slow-wave component in spike-wave discharges) 29 .
Synchrony by definition is an emergent feature of population dynamics, rather than a property of any single neuron, but an increase in cortical synchrony may arise from a whole range of different neuronal coupling changes. Many of these can be captured in models that specifically model cortical microcircuitry at the mesoscale; i.e. as neuronal ensembles 21, 30, 31 . The DCM approach adopted here uses this mesoscale modelling to identify the changes underlying the emergence of hypersynchronous slow wave activity, in the context of NMDAR-Ab.
NMDAR-Ab cause laminar specific changes in cortical dynamics
Dynamic causal modelling rests on neural mass modelling of coupled neuronal oscillators that are described using specific synaptic parameters (e.g. connection strengths, time constants, activation parameters) and that broadly resemble the laminar structure of the cortex. The neural mass model of a single electromagnetic source contains two pairs of coupled neuronal oscillators that support slower (deep oscillator: deep pyramidal cells, inhibitory interneurons) and faster (superficial oscillator: superficial pyramidal cells, spiny stellate cells) activity 32 . These population dynamics modelling cortical system (in this case, a single cortical column), with individual parameters that exert highly non-linear effects on the system is output. The parameterisation of these models is rooted in biophysical properties of individual neurons, but describe average characteristics of populations of functionally related neurons; i.e., composite properties emerging from the features of individual cells 21, 30, 31 .
At this mesoscale, PTZ and NMDAR-Ab produce synergistic effects that result in excessive synchrony not seen in other experimental conditions. Our results suggest that increases in low frequency power can be explained by a combination of: (1) an increase in superficial cortical excitatory coupling, largely associated with PTZ exposure, and (2) opposing changes in the dynamics of the superficial oscillator pair (spiny stellate and superficial pyramidal cells, Fig 3) .
The changes in synaptic dynamics align time constants in a gradient along the CMC coupling chain, with the slowest time constants in the deep pyramidal cells, and fastest time constants in the superficial pyramidal cells -and gradual steps between. This reduces the stepwise difference in time constants along the CMC chain compared to the standard CMC configuration. This parameterisation allows a dominant frequency to resonate across -and recruit -the whole column, thus producing the high amplitude slow frequency patterns observed. Thus interestingly, slow wave activity appears to be under the control of the faster, superficial oscillator pair in the CMC model, with both NMDAR-Ab and PTZ having profound and relatively specific effects on their dynamics. This is in keeping observations from invasive recordings of slow wave activity in human patients with epilepsy, which implicate superficial cortical coupling in the regulation of slow wave sleep activity 33 .
Different molecular changes show converging effects at the neuronal population level
The synaptic parameters of the CMC model employed in DCM are population summaries of a variety of cellular effects, encompassing emergent properties and multiple nonlinearities 34 . Time constants at the population level are essentially descriptions of the dynamics of post-synaptic integration affected by multiple factors, such as background firing frequency, membrane conductance, intra-and extracellular ion composition, and the dynamics of receptor types present in the membrane to name but a few 35 .
Connection strengths at the population level summarise the effect one population has over another, and may include effects mediated via subpopulations within (e.g. self-connections are assumed to be mediated via local inhibitory interneuronal populations). Because a number of different effects may converge on the same population parameters -and individual molecular effects may only be expressed in certain conditions -the link between molecular change and population parameters is nontrivial.
Exposure to NMDAR-Ab has been reported to cause a number of changes in the postsynaptic glutamate response, including a reduction in overall postsynaptic potential, a reduction in late postsynaptic currents, and a faster return to baseline 10, 11 . In intact neuronal circuits, NMDAR exert differential control over excitatory and inhibitory populations, leaving the populations differentially affected by NMDAR-blockade 16, 36 .
PTZ is believed to act as an antagonist to γ-Aminobutyric acid type A (GABA-A) receptors by directly blocking ionophores 37 . GABA-A receptors are fast inhibitory receptors with a wide-spread, region and cell-type specific set of post-synaptic effects 38 . These include inhibitory post-synaptic potentials, but also inhibition of dendritic excitatory post synaptic potentials via extrasynaptic GABA-A receptors, which is particularly pronounced at the cortical pyramidal cells 39 . In some neuronal cell types and at certain developmental stages GABA-A can cause excitatory post synaptic potentials 40 , and GABA transmission can exert direct or indirect control over excitatory NMDAR-dependent synaptic transmission 41, 42 .
With this range of different cellular effects, it is unlikely one can capture the breadth of NMDAR-Ab and PTZ related effects in a small subset of population model parameters. However, the effects on deltaband power can be reproduced well with a few principal components; comprising largely just two main effects: (1) decreasing the time constants of superficial pyramidal cells relative to excitatory spiny stellate cells, and (2) increasing the excitatory coupling between spiny stellate and superficial pyramidal cells.
There are a number of possible and convergent changes at the molecular level associated with NMDAR-Ab and PTZ exposure that could explain these population level effects. The time constant changes in superficial pyramidal cells may result from being switched towards (faster) AMPA mediated excitatory inputs (due to the NMDAR-Ab mediated internalisation of NMDAR) and a change in membrane conductivity (due to PTZ-mediated blocking of extrasynaptic GABA-A receptors). The change in excitatory connection, on the other hand, is consistent with a disinhibition of excitatory EPSPs under GABA-A blockade with PTZ (i.e. a block of so-called shunting inhibition) 39 .
NMDAR-Ab sensitise the cortical column to spontaneous paroxysmal EEG
In the patients with NMDAR-Ab encephalitis, there is no experimental control over NMDAR-Ab exposure, and our sample of patients is heterogeneous, representative of clinical practice (e.g. age, gender, timing of EEG, timing of initial diagnosis, etc). Moreover, these patients show a diverse range of paroxysmal, short-term changes in EEG dynamic patterns that are visually apparent, allowing us to probe spontaneous fluctuations of DCM parameters that may underlie discrete pathological brain states.
Patient-specific modelling, as facilitated by DCM, allows inference on patient-specific parameters in a generic model of the cortical column. Thus applying DCM analysis to this diverse sample, one can access two types of results: (1) Qualitative: i.e., identify the parameters whose changes underlie the dynamic abnormalities seen in EEG; (2) Quantitative: i.e., establish the numerical range of parameter fluctuations that can be applied to other specified DCMs.
Surprisingly, and despite the variety of EEG abnormalities described, consistently across patients, models with changes in time constants -i.e. synaptic transmission dynamics -best explained the observed transitions between background activity and paroxysms. Furthermore, we could summarise changes in these parameters along a single (principal component) axis. We used this component to enforce similar fluctuations in the fully specified DCMs derived from the mouse model analysis; asking whether the baseline context (i.e. the parameterisation derived from NMDAR-Ab positive or control animals) alters the impact of parameter changes of the magnitude observed in human patients.
Indeed the dynamic responses of the two types of models are very different: In the context of NMDAR-Ab, overall greater delta-band power is observed, and there are regimes of parameter space that contain boundaries between very different dynamic states 43 . This structural instability underwrites phase transitions of the sort seen in seizure activity. In the control parameterisation, the same changes have a much less pronounced effect, and do not induce overt slow wave paroxysms. In short, it appears that paroxysmal EEG activity in patients may be best explained by normal fluctuations in synaptic time constants that occur in an abnormal regime of synaptic parameter space.
Overall, these findings provide integrative evidence from human patients and a mouse model of NMDAR-Ab encephalitis suggesting that (1) NMDAR-Ab cause electrophysiological abnormalities via a small number of synaptic changes, which may lend themselves to targeted therapeutic interventions; e.g., by exploiting laminar and/or cell-type specific effects of transcranial current stimulation. 44 And (2) paroxysmal abnormalities can be explained by persistent baseline changes that render cortical microcircuitry particularly sensitive to (potentially normal) fluctuations in synaptic coupling. Future research may reveal whether similar approaches have diagnostic value when performed on patient EEGs alone.
Limitations
The modelling approach presented here allows unique insights into possible mechanisms underlying empirically observed phenomena. Although DCM has been applied to a wide variety of neurophysiological studies -and its validity has been assessed repeatedly 19, 20, 45 -there are certain limitations to the approach adopted here.
First, the modelling can only be applied to existing data -this places restrictions on study design (e.g. pre-NMDAR-Ab exposure EEGs are not usually available from patients) and limit the approach to a subset of testable hypotheses. Second, like all inference, DCM is based on specific assumptions regarding the underlying neuronal architecture -all activity presented here is presumed to emerge from microcircuitry consistent with the CMC model, and only given this assumptions can we estimate the parameters and evidence for or against specific model configurations.
Most importantly, we have reduced a complex brain-wide pathology of interacting systems to changes in a cortical microcircuit. Thus, we are ignoring interactions between different cortical regions, as well as the influence of subcortical structures, such as thalamus and brain stem, which (especially in the context of encephalopathy and slow wave abnormalities) will exert a powerful influence over cortical states. Although these effects can be accommodated in the model as random effects, they are not modelled explicitly.
Methods
Collection and classical analysis of mouse LFP
The mouse model and associated procedures have been previously described 9 . Briefly, plasma with NMDAR-Ab (Immunoglobulin G, IgG) was obtained with informed consent from three female NMDAR-Ab positive patients with neuropsychiatric features, movement disorder and reduced level of consciousness. Control IgG was purified from serum from two healthy individuals. C57BL/6 female mice aged 8-10 weeks were housed and examined according to ARRIVE guidelines and all analyses were performed with the observer blinded to injected antibody.
Wireless telemetry transmitters (Subcutaneous transmitter A3028B-CC from Open Source Instruments Inc) were implanted in a subcutaneous pocket over the right flank. Two craniotomies were performed at 1mm lateral and 1mm caudal from bregma. Electrode screws were fixed into the drilled holes with dental cement. After a five-day monitored recovery period, eight microliters of purified IgG (patient, or control) was injected slowly into the left lateral ventricle through a single additional craniotomy made 1mm left lateral and 0.45mm caudal from bregma.
Mice were housed in a Faraday cage during wireless LFP data collection. To test seizure susceptibility, 40mg/kg of PTZ was given intra-peritoneally and the mice were observed for 45 minutes following injection. The 45-minute time period immediately preceding PTZ injection was used as control segment.
Raw LFP data was analysed in Matlab. Sliding-window (30s windows, 15s steps) Fourier estimates of power over frequency were used to statistically compare the different conditions. ANOVA over mean delta-band power (1-4Hz) was used to estimate the effects of the two main interventions (NMDAR-Ab, PTZ) and their interaction on LFP signal composition.
DCM analysis of mouse LFPs
Modelling of the mouse LFP recordings can be divided into the following steps (summarised in Fig 6) . Dynamic causal modelling was performed using SPM12, an academic software package (www.fil.ion.ucl.ac.uk/spm). All analysis code and raw data are available online (https://github.com/roschkoenig/NMDAR_Encephalitis, requires Matlab 2014b or later and SPM12). Individual time windows were assumed to be relatively stationary within the 30s sliding time window in line with previous DCM analyses of EEG seizure activity 23, 46 . Each time window was modelled as originating from a single cortical source comprising four coupled neuronal populations (i.e. a single cortical column modelled as single CMC). DCM employs a standard variational Laplace scheme to fit the parameters of a specified neural mass model to empirical data 18 , whilst also providing a (free energy) measure of the Bayesian model evidence. The combination of posterior parameter estimates and free energy subsequently allows for computationally efficient modelling of group effects across individual DCMs, further exploited with the PEB analysis 22 .
A second level model (PEB) was used to estimate parameter changes associated with the experimental modulations. Specifically, each time window was associated with a numerical value representing the absence or presence of NMDAR-Ab (0 or 1), the estimated PTZ concentration (range 0 to 1, modelled as first order kinetics after intraperitoneal injection), and an interaction term (range -1 to 1). PEB employs Bayesian model reduction based on the effects specified model parameters, effectively modelling between-window changes in parameter as a mixture of random effects and systematic modulation of each parameter by the main effects provided in the PEB model specification. Thus, inversion at the second (between-window) level provides posterior parameter estimates for first level model parameters (i.e. neuronal physiology) that are associated with second level parameters (i.e. experimental modulation) across the whole series of individual DCMs. The DCMs are fully specified models of spontaneous neuronal activity and can therefore be used to explore individual parametric effects on overall spectral output. Here, we utilise the parameter estimates derived as the group mean in the PEB analysis as baseline. We then extract the first principal components of time constant, and connection strength variations across all individual time window DCMs (Fig 6E) , providing a summary of covarying changes in parameters that explain most of the variance among samples. We then systematically vary the contribution of each of these two components in 300 discrete steps each around the baseline estimates. This yields 300*300 = 90,000 parameterisations for a single source DCM, and for each of these the spectral output can be estimated. We can use this to visualise scalar output measures (e.g. log mean delta band power) across a section of a two-dimensional parameter space (Fig 6F) . This combines the benefits of fitting generative (i.e. forward) models to empirical data (i.e. data features to model parameters), and exploring the effects of specific parameters on model output through forward modelling (i.e. model parameters to data features 47, 48 ).
In a last step, we apply the first principal component of the parameter variations in time constants derived from the patient sample NMDAR-Ab positive and control baseline parameterisations of the DCM, to explore the condition specific responses of the cortical column parameterisation to fluctuations in the time constant parameters. We then use and inverse Fourier analysis to illustrate the sort of paroxysmal responses that would be expected based on the spectral predictions under specific parameter combinations (Fig 6H) 
Patient selection and EEG recording
Patients were selected from routine clinical service at a tertiary paediatric specialist hospital that is a regional referral centre for patients with presumed autoimmune encephalitis. Patients were selected based on (1) symptoms consistent with autoimmune encephalitis, (2) positive laboratory testing for NMDAR-Ab at some point during their clinical course, (3) availability of routine clinical EEG recording during the acute phase of their illness, (4) presence of visually apparent EEG abnormalities. Anonymised clinical information was provided by the patients' care team with written, informed consent provided by the patients' legal guardians. All patients met the Graus criteria for a clinical diagnosis of NMDAR-Ab encephalitis 49 .
All EEGs used in this analysis were standard clinical recordings (21 electrodes, International 10-20 Electrode Layout, 30 min recording time, 256 Hz sampling frequency, 1-70 Hz digital Butterworth bandpass filter). EEGs were visually analysed by two clinicians with expertise in EEG interpretation (RER, GC), identifying paroxysmal abnormalities, as well as segments of artefact free awake background EEG that were used for further analysis.
DCM analysis of patient EEG paroxysms
EEG analysis was designed to identify mechanisms underlying the frequently observed paroxysmal abnormalities in patients with NMDAR-Ab encephalitis. The purpose of this modelling approach is to identify a small set of parameters that can explain the transition between background activity and EEG paroxysms for each individual patient. The analysis can broadly be summarised as follows (also shown in Fig 7) . Patients were selected on clinical EEG with reported dynamic abnormalities (ranging from evidence of mild encephalopathy to overt epileptiform activity). EEGs were reviewed by two clinicians with EEG experience (RER, GC) and segments containing normal awake background, as well as paroxysmal abnormalities (isolated slow waves, intermittent rhythmic slow activity, and overt epileptiform activity) identified. Paroxysmal activity was averaged across visually identified 2s windows and source localised using an IID (independent and identically distributed) approach in SPM12 50 . At the cortical location with maximal activity, a single virtual electrode trace was extracted for each of the paroxysmal and background activity windows and used for further DCM analysis 46 . Table 2 : Free parameters fitted by the DCM τ 1 (superficial pyramidal cell time constant) g 1 (sp to ss inhibition) τ 2 (spiny stellate time constant) g 2 (ii to ss inhibition) τ 3 (inhibitory interneuron time constant) g 3 (ii to ip inhibition) τ 4 (deep pyramidal cell time constant) g 4 (ss to sp excitation) g 5 (ss to ii excitation) g 6 (dp to ii excitation) g 7 (sp self modulation) g 8 (ss self modulation g 9 (ii self modulation g 10 (dp self modulation This 'virtual LFP' activity was modelled using a single CMC source. An average of all paroxysm time windows, and all background time windows was inverted separately, producing 2-3 fully specified DCMs per subject. These were subsequently combined into a single hierarchical (PEB) model for each patient, in which only a subset of specific parameters were allowed to vary. A model space was created at the level of these second level models were either time constants, inhibitory between-population connections, excitatory between-population connections, or inhibitory self modulatory connections were allowed to vary to explain the difference between paroxysms and background activity (see Tab 2) . Random effects Bayesian model comparison across these second level models uses the approximation to model evidence from the variational Laplace model inversion (i.e. the free energy) to compare the evidence for any given model parameterisation, given the empirical data 19 . 
